Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Eli Lilly (LLY) Stock Near $1 Trillion: Zepbound Price Cuts, New $6B Plant and 2026 Dividend Hike – Is It Still a Buy?

Eli Lilly (LLY) Stock Near $1 Trillion: Zepbound Price Cuts, New $6B Plant and 2026 Dividend Hike – Is It Still a Buy?

As of mid‑day trading on December 10, 2025, Eli Lilly is changing hands at around $980 per share, down slightly on the day and just below its recent all‑time high above $1,050. That price values Lilly at roughly $930–$1,000+ billion in market cap, depending on intraday moves, placing it in the same league as mega‑cap tech giants and making it the first healthcare company ever to cross the $1 trillion mark. Reuters
1 803 804 805 806 807 891
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Walt Disney

NYSE: DIS 94 / 100
#2 BUY

AerCap

NYSE: AER 92 / 100
#3 TACTICAL BUY

Advanced Micro Devices

NASDAQ: AMD 90 / 100
#4 BUY ON WEAKNESS

Arista Networks

NYSE: ANET 88 / 100
#5 SPECULATIVE BUY

Albemarle

NYSE: ALB 85 / 100
View full portfolio
Editorial model selection. Not personalised advice.